- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07324694
Inverkan av intraoperativ hemodynamisk instabilitet på utfall vid hjärtkirurgi
Inverkan av intraoperativ hemodynamisk instabilitet på postoperativa allvarliga biverkningar hos hjärtkirurgipatienter: En prospektiv kohortstudie
Intraoperative hemodynamic instability (IOHI) is a common occurrence during cardiac surgery and is associated with organ hypoperfusion. However, the specific impact of IOHI on composite adverse outcomes remains unclear. This prospective cohort study aims to evaluate the association between intraoperative hemodynamic instability (defined as MAP < 65 mmHg or vasopressor requirement) and major postoperative complications (Delirium, Acute Kidney Injury, Stroke, or Mortality) in adult patients undergoing elective cardiac surgery with cardiopulmonary bypass.
Studieöversikt
Status
Detaljerad beskrivning
Hemodynamic instability during cardiac surgery is a critical factor influencing postoperative recovery. While transient hypotension is common, prolonged instability may lead to end-organ damage due to hypoperfusion. This prospective observational study will be conducted at the University of Health Sciences Gazi Yasargil Training and Research Hospital.
Patients scheduled for elective cardiac surgery (Coronary Artery Bypass Grafting, Valve replacement/repair, or combined procedures) utilizing cardiopulmonary bypass will be enrolled. Intraoperative hemodynamic data, including Mean Arterial Pressure (MAP), heart rate, and vasoactive medication requirements, will be recorded.
Patients will be categorized into two groups based on intraoperative stability:
- Hemodynamic Instability Group: Patients experiencing MAP < 65 mmHg for more than 5 minutes continuously or requiring significant vasopressor/inotropic support to maintain target pressure.
- Stable Group: Patients maintaining hemodynamic stability without significant hypotensive episodes.
The primary endpoint is a composite of major adverse events within 30 days, including Postoperative Delirium (assessed via CAM-ICU), Acute Kidney Injury (KDIGO criteria), Stroke, and All-cause Mortality. Secondary endpoints include the duration of mechanical ventilation and length of ICU/hospital stay. The study aims to provide evidence-based thresholds for intraoperative blood pressure management to improve patient outcomes.
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
Diyarbakır
-
Diyarbakır, Diyarbakır, Turkiet (Türkiye), 21070
- Gazi Yaşargil Training and Research Hospital
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Adult patients undergoing elective cardiac surgery with cardiopulmonary bypass at a tertiary care university hospital.
Beskrivning
Inclusion Criteria:
- Patients aged 18 years or older.
- Scheduled for elective cardiac surgery (CABG, Valve replacement/repair, or combined procedures).
- Surgery performed under cardiopulmonary bypass (CPB).
- Preoperative sinus rhythm.
- Signed informed consent form.
Exclusion Criteria:
- Emergency or salvage surgery.
- Off-pump coronary artery bypass grafting.
- Preoperative mechanical circulatory support (IABP, ECMO) requirement.
- Pre-existing chronic renal failure requiring dialysis (HD/PD).
- Pre-existing cognitive impairment, dementia, or history of psychiatric disorders affecting cooperation.
- Pregnancy.
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: COHORT
- Tidsperspektiv: PROSPECTIVE
Kohorter och interventioner
Grupp / Kohort |
|---|
|
Hemodynamic Instability Group
Patients who exhibit intraoperative hemodynamic instability, defined as Mean Arterial Pressure (MAP) < 65 mmHg for >5 minutes continuously, or requiring vasopressor/inotropic support to maintain MAP. |
|
Hemodynamically Stable Group
Patients who maintain intraoperative hemodynamic stability without significant hypotension episodes (MAP > 65 mmHg) or vasopressor requirement beyond baseline anesthesia induction. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Incidence of Composite Adverse Events
Tidsram: Up to 30 days post-operation
|
A composite endpoint defined as the occurrence of any of the following within 30 days post-surgery: Postoperative Delirium (assessed by CAM-ICU), Acute Kidney Injury (KDIGO criteria stage 1 or higher), Stroke (new neurological deficit confirmed by imaging), or All-cause Mortality. |
Up to 30 days post-operation
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Duration of Mechanical Ventilation
Tidsram: Up to 30 days
|
Time from ICU admission to successful extubation (in hours). |
Up to 30 days
|
|
Length of Hospital Stay
Tidsram: Up to 30 days
|
Total duration of hospital stay from surgery to discharge (in days) |
Up to 30 days
|
|
Length of Intensive Care Unit (ICU) Stay
Tidsram: Up to 30 days
|
Time from admission to the Intensive Care Unit immediately after surgery until discharge to the ward (in days). |
Up to 30 days
|
Samarbetspartners och utredare
Publikationer och användbara länkar
Allmänna publikationer
- Buitenwerf E, Boekel MF, van der Velde MI, Voogd MF, Kerstens MN, Wietasch GJKG, Scheeren TWL. The haemodynamic instability score: Development and internal validation of a new rating method of intra-operative haemodynamic instability. Eur J Anaesthesiol. 2019 Apr;36(4):290-296. doi: 10.1097/EJA.0000000000000941.
- Shen X, Tao H, Chen W, Sun J, Jin R, Zhang W, Hong L, Zhang C. Perioperative blood pressure variability as a risk factor for postoperative delirium in the patients receiving cardiac surgery. BMC Anesthesiol. 2024 Nov 25;24(1):424. doi: 10.1186/s12871-024-02817-x.
- D'Amico F, Fominskiy EV, Turi S, Pruna A, Fresilli S, Triulzi M, Zangrillo A, Landoni G. Intraoperative hypotension and postoperative outcomes: a meta-analysis of randomised trials. Br J Anaesth. 2023 Nov;131(5):823-831. doi: 10.1016/j.bja.2023.08.026. Epub 2023 Sep 20.
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
- Urogenitala sjukdomar
- Neurologiska manifestationer
- Sjukdomar i nervsystemet
- Mentala störningar
- Patologiska processer
- Manliga urogenitala sjukdomar
- Njursjukdomar
- Urologiska sjukdomar
- Kvinnliga urogenitala sjukdomar
- Kvinnliga urogenitala sjukdomar och graviditetskomplikationer
- Förvirring
- Neurobehavioral manifestationer
- Neurokognitiva störningar
- Njurinsufficiens
- Delirium
- Patologiska tillstånd, tecken och symtom
- Tecken och symtom
- Emergence Delirium
- Akut njurskada
- Postoperativa komplikationer
Andra studie-ID-nummer
- GYTRH-KVC-IOHI-01
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .